UPEXI, INC.
For the period ended Jun 30, 2026. Filed Sep 17, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2026 · Filed Sep 17, 2026
UPXI$0.66+3.8%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
| June 30, | ||
|---|---|---|
| 2026 | 2025 | |
| ASSETS | ||
| Current assets | ||
| Cash | $5,778,586 | $2,975,150 |
| Accounts receivable, net | 97,244 | 157,515 |
| Inventory, net | 265,961 | 1,152,870 |
| Due from VitaMedica transition | 10,766 | 228,017 |
| Prepaid expenses and other assets | 988,542 | 350,836 |
| Current digital assets at fair value | 109,625,166 | 49,913,655 |
| Purchase price receivable - VitaMedica | - | 2,000,000 |
| Total current assets | 116,766,265 | 56,778,043 |
| Property and equipment, net | 208,044 | 2,052,573 |
| Intangible assets, net | 86,353 | 163,113 |
| Goodwill | 673,854 | 848,854 |
| Deferred tax asset | 5,948,858 | 5,948,858 |
| Digital assets at fair value, net of current | 55,675,516 | 56,083,525 |
| Other assets | 163,223 | 192,123 |
| Right-of-use asset, net | 598,678 | 1,739,755 |
| Total noncurrent assets | 63,354,526 | 67,028,801 |
| Total assets | $180,120,791 | $123,806,844 |
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||
| Current liabilities | ||
| Accounts payable | $277,644 | $1,039,370 |
| Accrued compensation | 5,277,309 | 3,470,296 |
| Deferred revenue | 4,519 | 13,155 |
| Accrued liabilities | 1,675,521 | 356,064 |
| Accrued interest | 2,349,162 | 792,449 |
| Acquisition payable | 260,652 | 260,652 |
| Current portion of promissory notes | - | 560,000 |
| Short-term treasury debt | 57,295,723 | 20,000,000 |
| Current portion of Cygnet subsidiary notes payable | 3,694,721 | 5,380,910 |
| Current portion of operating lease payable | 295,167 | 691,010 |
| Total current liabilities | 71,130,418 | 32,563,906 |
| Operating lease payable, net of current portion | 362,235 | 1,145,440 |
| Convertible notes payable | 162,442,056 | - |
| Total long-term liabilities | 162,804,291 | 1,145,440 |
| Stockholders' equity | ||
| Preferred stock, $0.00001 par value, 10,000,000 shares authorized, and 150,000 shares issued and outstanding | 2 | 2 |
| Common stock, $0.00001 par value, 1,000,000,000 shares authorized, 78,702,358 and 38,270,571 shares issued and outstanding, as of June 30, 2026 and June 30, 2025, respectively | 787 | 383 |
| Additional paid in capital | 252,793,813 | 150,640,935 |
| Accumulated deficit | (306,608,520) | (60,543,822) |
| Total stockholders' equity | (53,813,918) | 90,097,498 |
| Total liabilities and stockholders' equity | $180,120,791 | $123,806,844 |
UPEXI, INC.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.